acivicin has been researched along with African Sleeping Sickness in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrett, MP; Conti, P; Cosconati, S; De Micheli, C; Iannuzzi, MC; Lo Presti, L; Major, LL; Marinelli, L; Novellino, E; Pinto, A; Smith, TK; Tamborini, L; Wong, PE | 1 |
Brun, R; Chabes, A; Hofer, A; Steverding, D; Thelander, L | 1 |
2 other study(ies) available for acivicin and African Sleeping Sickness
Article | Year |
---|---|
Synthesis and biological evaluation of CTP synthetase inhibitors as potential agents for the treatment of African trypanosomiasis.
Topics: Carbon-Nitrogen Ligases; Enzyme Inhibitors; HeLa Cells; Humans; Isoxazoles; Molecular Docking Simulation; Pyrazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2012 |
Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness.
Topics: Adenosine Triphosphate; Animals; Carbon-Nitrogen Ligases; Cells, Cultured; Cytidine; Cytidine Triphosphate; Diazooxonorleucine; Enzyme Inhibitors; Fibroblasts; Guanine; Guanosine Triphosphate; Humans; Hypoxanthines; Intracellular Fluid; Isoxazoles; Mice; Mice, Inbred BALB C; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African; Uridine Triphosphate | 2001 |